Items where Author is "Kanavos, Panos"

Leon, Giovanny, Gonzalez-Pier, Eduardo, Kanavos, Panos ORCID: 0000-0001-9518-3089, Ruiz de Castilla, Eva Maria and Machinicki, Gerardo (2024) The 30-billion-dollar distribution markups and taxes of pharmaceuticals in Latin American countries: impact, options, and trade-offs. Value in Health Regional Issues, 44. ISSN 2212-1099

Kanavos, Panos ORCID: 0000-0001-9518-3089, Leon, Giovanny, Carbonel, Christophe, Rampuria, Aparajit, Singh Rajpoot, Ravindra and Joshi, Parth (2024) An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines: evidence from 35 countries. European Journal of Health Economics. ISSN 1618-7598

Augustovski, Federico, Colaci, Carla, Mills, Mackenzie, Chávez, Danitza, Argento, Fernando, Alfie, Verónica, Pichon Riviere, Andrés, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Alcaraz, Andrea (2024) A systematic review of value criteria for next-generation sequencing/ comprehensive genomic profiling to inform value framework development. Value in Health, 27 (5). 670 - 685. ISSN 1098-3015

Main, Caitlin, Haig, Madeleine, Chávez, Danitza and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2024) Assessing the value of provider-facing digital health technologies used in chronic disease management:: toward a value framework based on multistakeholder perceptions. Medical Decision Making, 44 (1). 28 - 41. ISSN 0272-989X

Gill, Jennifer L, Chávez, Danitza, Main, Caitlin, Miracolo, Aurelio and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) HPR85 Opinions on sustainable healthcare financing options for funding new medical technologies in Asean-6. Value in Health, 26 (12). S268 - S269. ISSN 1098-3015

Kanavos, Panos ORCID: 0000-0001-9518-3089, Alcaraz, OA, Chávez, Danitza, Colaci, C, Haig, Madeleine, Argento, F, Main, Caitlin, Alfie, Verónica, Mills, Mackenzie, Pichon-Riviere, DA and Augustovski, F (2023) HTA187 Advancing a collaborative value assessment framework for Next-Generation Sequencing/ Comprehensive Genomic Profiling in Europe: building on and enhancing an existing framework - a multi-stakeholder web-Delphi approach. Value in Health, 26 (12). S355 - S355. ISSN 1098-3015

Politopoulou, Konstantina, Mills, Mackenzie and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) HTA255 First-in-class drugs in HTA: blunder or bliss? Value in Health, 26 (12). S369 - S369. ISSN 1098-3015

Gill, Jennifer L, Miracolo, Aurelio, Politopoulou, Konstantina, Jayawardana, Sahan ORCID: 0000-0001-7081-3910, Apostolou, Efstratios A., Carter, Alex ORCID: 0000-0003-3793-407X and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) MSR1 Estimating lifetime benefits of optimizing secondary preventive treatment for atherosclerotic cardiovascular disease. Value in Health, 26 (12). S393 - S393. ISSN 1098-3015

Main, Caitlin, Haig, Madeleine and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) P36 Towards a collaborative value assessment framework for provider-facing digital health technologies used in chronic disease management: Findings and Implications. Value in Health, 26 (12). S9 - S9. ISSN 1098-3015

Fontrier, Anna-Maria, Kamphuis, Bregtje W. and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe. European Journal of Health Economics. ISSN 1618-7598

Apostolou, Efstratios A., Fontrier, Anna Maria, Efthimiadis, Georgios K., Kastritis, Efstathios, Parissis, John and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) The patient pathway in ATTR-CM in Greece and how to improve it: a multidisciplinary perspective. Hellenic Journal of Cardiology, 73 (September–October 2023). 73 - 80. ISSN 1109-9666

Angelis, Aris ORCID: 0000-0002-0261-4634, Montibeller, Gilberto Neto and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) A structured methodology for essential medicines lists and health emergency stockpiles: experience with the Emergency Medicines Buffer Stock in the United Kingdom. Social Science and Medicine, 337. ISSN 0277-9536

Mills, Mackenzie and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) Healthcare payer perspectives on the assessment and pricing of oncology multi-indication products: evidence from nine OECD countries. PharmacoEconomics - Open, 7 (4). 553 - 565. ISSN 2509-4262

Fontrier, Anna-Maria and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) Do reimbursement recommendations by the Canadian Agency for Drugs and Technology in Health translate into coverage decisions for orphan drugs in the Canadian province of Ontario? Value in Health, 26 (7). 1011 - 1021. ISSN 1098-3015

Haig, Madeleine, Main, C, Chavez, D and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) Navigating the digital health landscape for chronic disease management: a value assessment framework for patient-facing technologies. Value in Health, 26 (6). S8 - S8. ISSN 1098-3015

Haig, Madeleine, Main, Caitlin, Chávez, Danitza and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) A value framework to assess patient-facing digital health technologies that aim to improve chronic disease management: a Delphi approach. Value in Health, 26 (10). pp. 1474-1484. ISSN 1098-3015

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Vandoros, Sotiris (2023) Road traffic mortality and economic uncertainty: evidence from the United States. Social Science & Medicine, 326. ISSN 0277-9536

Mills, Mackenzie, Michaeli, Daniel, Miracolo, Aurelio and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countries. BMC Health Services Research, 23 (1). p. 150. ISSN 1472-6963

Gill, Jennifer, Miracolo, Aurelio, Politopoulou, Konstantina, Jayawardana, Sahan ORCID: 0000-0001-7081-3910, Carter, Alex ORCID: 0000-0003-3793-407X, Apostolou, Efstratios A. and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) How can we improve secondary prevention of cardiovascular disease? . Medical Technology Research Group (MTRG), The London School of Economics and Political Science, London, UK.

Gill, Jennifer, Chávez, Danitza, Main, Caitlin, Miracolo, Aurelio, Fontrier, Anna-Maria and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) Sustainable healthcare financing for SDG3 in ASEAN-6. . Medical Technology Research Group (MTRG), The London School of Economics and Political Science, London, UK.

Efthymiadou, Olina and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2022) Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries. BMC Health Services Research, 22 (1). ISSN 1472-6963

Angelis, A. ORCID: 0000-0002-0261-4634, Mellerio, J. E. and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2022) Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life study. Orphanet Journal of Rare Diseases, 17 (1). ISSN 1750-1172

Gill, Jennifer L, Mills, Mackenzie J, Wharton, George A ORCID: 0000-0001-6544-3636 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2022) The future of oncology policy. Journal of Cancer Policy, 34. ISSN 2213-5383

Mills, Mackenzie and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2022) How do HTA agencies perceive conditional approval of medicines? Evidence from England, Scotland, France and Canada. Health Policy, 126 (11). 1130 - 1143. ISSN 0168-8510

Main, Caitlin, Haig, Madeleine and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2022) The promise of population health management in England: from theory to implementation. . LSE Consulting.

Kanavos, Panos ORCID: 0000-0001-9518-3089, Vogelsang, Michelle, Haig, Madeleine and Kolovou, Vasiliki (2022) Challenges for health systems seeking to embrace virtual health care for population health. European Journal of Health Economics, 23 (7). 1079 - 1083. ISSN 1618-7598

Michaeli, Daniel Tobias, Mills, Mackenzie and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2022) Value and price of multi-indication cancer drugs in the USA, Germany, France, England, Canada, Australia, and Scotland. Applied Health Economics and Health Policy, 20 (5). 757 - 768. ISSN 1175-5652

Michaeli, Daniel Tobias, Mills, Mackenzie, Michaeli, Thomas, Miracolo, Aurelio and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2022) Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA. Investigational New Drugs, 40 (4). 798 - 809. ISSN 0167-6997

Efthymiadou, Olina, Kamphuis, Bregtje, Gill, Jennifer, Haig, Madeleine and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2022) Towards better outcomes in autism by addressing policy change. . London School of Economics and Political Science, London, UK.

Fontrier, Anna-Maria, Visintin, Erica and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2022) Similarities and differences in Health Technology Assessment systems and implications for coverage decisions: evidence from 32 countries. PHARMACOECONOMICS-OPEN, 6 (3). 315 - 328. ISSN 2509-4262

Kamphuis, Bregtje W. and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2021) Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration. Health Policy OPEN, 2. ISSN 2590-2296

Kamphuis, Bregtje, Fontrier, Anna-Maria, Haig, Madeleine, Politopoulou, Konstantina, Salyga, Hana, Gentilini, Arianna and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2021) Development of policies to increase headroom for innovation in Egypt and the Kingdom of Saudi Arabia. . LSE Consulting, London, UK.

Miracolo, Aurelio, Sophiea, Marisa, Mills, Mackenzie and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2021) Sin taxes and their effect on consumption, revenue generation and health improvement: a systematic literature review in Latin America. Health Policy and Planning, 36 (5). 790 - 810. ISSN 0268-1080

Kamphuis, Bregtje, Fontrier, Anna-Maria, Gill, Jennifer, Efthymiadou, Olina, Salyga, Hana and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2021) Access to medicines in Europe delays and challenges for patient access: delays and challenges for patient access. . LSE Consulting, London, UK.

Kamphuis, Bregtje, Efthymiadou, Olina, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Tzouma, Victoria (2021) Severe asthma care and treatment: indicators and data for performance management across ten countries. . LSE Consulting, London, UK.

Efthymiadou, Olina, Kamphuis, Bregtje, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Tzouma, Victoria (2021) Treatment gaps in severe asthma across nine OECD countries and recommendations for addressing them: an international survey of clinicians. . LSE Consulting, London, UK.

Kamphuis, Bregtje, Gill, Jennifer, Vogelzang, Michelle, Haig, Madeleine and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2021) The role of virtual health care and the pharmaceutical sector in improving population health. . LSE Consulting, London, UK.

Efthymiadou, Olina and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2021) Determinants of managed entry agreements in the context of Health Technology Assessment: a comparative analysis of oncology therapies in four countries. International Journal of Technology Assessment in Health Care, 37 (1). ISSN 0266-4623

Kanavos, Panos ORCID: 0000-0001-9518-3089, Kamphuis, Bregtje, Fontrier, Anna-Maria, Parkin, Georgia Colville, Saleh, Shadi and Akhras, Kasey S. (2020) Pricing of in-patent pharmaceuticals in the Middle East and North Africa: is external reference pricing implemented optimally? Health Policy, 124 (12). 1297 - 1309. ISSN 0168-8510

Angelis, Aris ORCID: 0000-0002-0261-4634, Thursz, Mark, Ratziu, Vlad, O'Brien, Alistair, Serfaty, Lawrence, Canbay, Ali, Schiefke, Ingolf, Bana e Costa, João C., Lecomte, Pascal and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2020) Early health technology assessment during nonalcoholic steatohepatitis drug development: a two-round, cross-country, multicriteria decision analysis. Medical Decision Making, 40 (6). 830 - 845. ISSN 0272-989X

Angelis, Aris ORCID: 0000-0002-0261-4634, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Phillips, Lawrence D. (2020) ICER value framework 2020 update: recommendations on the aggregation of benefits and contextual considerations. Value in Health, 23 (8). 1040 - 1048. ISSN 1098-3015

Mills, Mackenzie and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2020) Do pharmaceutical budgets deliver financial sustainability in healthcare? Evidence from Europe. Health Policy, 124 (3). pp. 239-251. ISSN 0168-8510

Angelis, Aris ORCID: 0000-0002-0261-4634, Linch, Mark, Montibeller, Gilberto, Molina Lopez, Maria Teresa, Zawada, Anna, Orzel, Kinga, Arickx, Francis, Espin, Jaime and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2020) Multiple criteria decision analysis for HTA across four EU member states: piloting the Advance Value Framework. Social Science & Medicine, 246. ISSN 0277-9536

Gill, Jennifer, Fontrier, Anna-Maria, Miracolo, Aurelio and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2020) Access to personalised oncology in Europe. .

Gill, Jennifer, Fontrier, Anna-Maria, Kyriopoulos, Dionysis and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2019) Variations in external reference pricing implementation: does it matter for public policy? European Journal of Health Economics, 20 (9). 1375 - 1397. ISSN 1618-7598

Fontrier, Anna-Maria, Gill, Jennifer and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2019) International impact of external reference pricing: should national policy makers care? European Journal of Health Economics, 20 (8). 1147 - 1164. ISSN 1618-7598

Kanavos, Panos ORCID: 0000-0001-9518-3089 (2019) Does external reference pricing deliver what it promises? Evidence on its impact at national level. European Journal of Health Economics, 21 (1). pp. 129-151. ISSN 1618-7598

Oliveira, Mónica D., Mataloto, Inês and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2019) Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art. European Journal of Health Economics, 20 (6). pp. 891-918. ISSN 1618-7598

Kanavos, Panos ORCID: 0000-0001-9518-3089, Parkin, Georgia Colville, Kamphuis, Bregtje and Gill, Jennifer (2019) Latin America healthcare system overview: a comparative analysis of fiscal space in healthcare. . LSE Consulting.

López-Bastida, Julio, Ramos-Goñi, Juan Manuel, Aranda-Reneo, Isaac, Taruscio, Domenica, Magrelli, Armando and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2019) Using a stated preference discrete choice experiment to assess societal value from the perspective of patients with rare diseases in Italy. Orphanet Journal of Rare Diseases, 14 (1). ISSN 1750-1172

Kanavos, Panos ORCID: 0000-0001-9518-3089, Mills, Mackenzie and Zhang, Anwen (2019) Pharmaceutical policy in China. . LSE Consulting, London, UK.

Kanavos, Panos ORCID: 0000-0001-9518-3089, Angelis, Aris ORCID: 0000-0002-0261-4634 and Drummond, Michael (2019) An EU-wide approach to HTA: an irrelevant development or an opportunity not to be missed? European Journal of Health Economics, 20 (3). pp. 329-332. ISSN 1618-7598

López-Bastida, J., Ramos-Goñi, J. M., Aranda-Reneo, I., Trapero-Bertran, M., Kanavos, Panos ORCID: 0000-0001-9518-3089 and Rodriguez Martin, B. (2019) Using a stated preference discrete choice experiment to assess societal value from the perspective of decision-makers in Europe. Does it work for rare diseases? Health Policy, 123 (2). pp. 152-158. ISSN 0168-8510

Visintin, Erica, Tinelli, Michela ORCID: 0000-0002-8816-4389 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2019) Value assessment of disease-modifying therapies for Relapsing-Remitting Multiple Sclerosis: HTA evidence from seven OECD countries. Health Policy, 123 (2). pp. 118-129. ISSN 0168-8510

Efthymiadou, Olina, Mossman, Jean and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2018) Health related quality of life aspects not captured by EQ-5D-5L: results from an international survey of patients. Health Policy. ISSN 0168-8510

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Sandberg, Dale M., Pillay, Anban and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2018) The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period. Social Science & Medicine. ISSN 0277-9536

Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2018) Comment on: “Does MCDA trump CEA?”. Applied Health Economics and Health Policy. ISSN 1175-5652

Efthymiadou, Olina, Mossman, Jean and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2018) Differentiation of health related quality of life outcomes between five disease areas; results from an international survey of patients. International Journal of Technology Assessment in Health Care, 34 (5). pp. 498-506. ISSN 0266-4623

Gill, Jennifer, Baiceanu, Andrei, Clark, Paul J, Langford, Andrew, Latiff, Julianah, Yang, Pei-Ming, Yoshida, Eric M and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2018) Insights into the hepatocellular carcinoma patient journey: results of the first global quality of life survey. Future Oncology, 14 (17). pp. 1701-1710. ISSN 1479-6694

Tinelli, Michela ORCID: 0000-0002-8816-4389, Efthymiadou, Olina, Mossman, Jean and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2018) OP141 Patient relevant outcome measures as predictors of health care use in multiple sclerosis. International Journal of Technology Assessment in Health Care, 33 (S1). ISSN 0266-4623

Angelis, Aris ORCID: 0000-0002-0261-4634, Lange, Ansgar and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2018) Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries. European Journal of Health Economics, 19 (1). pp. 123-152. ISSN 1618-7598

Gill, Jennifer, Kanavos, Panos ORCID: 0000-0001-9518-3089, d'Angela, Daniela, Berger, Karin, Dank, Magdolna, Duncombe, Robert, Fink-Wagner, Antje, Hutton, John, Kossler, Ingrid, Podrazilova, Katerina and Thomas, Michael (2018) RWE in Europe Paper IV: Engaging pharma in the RWE Roadmap. . London School of Economics and Political Science, London, UK.

Ferrario, Alessandra, Arāja, Diāna, Bochenek, Tomasz, Čatić, Tarik, Dankó, Dávid, Dimitrova, Maria, Fürst, Jurij, Greičiūtė-Kuprijanov, Ieva, Hoxha, Iris, Jakupi, Arianit, Laidmäe, Erki, Löblová, Olga, Mardare, Ileana, Markovic-Pekovic, Vanda, Meshkov, Dmitry, Novakovic, Tanja, Petrova, Guenka, Pomorski, Maciej, Tomek, Dominik, Voncina, Luka, Haycox, Alan, Kanavos, Panos ORCID: 0000-0001-9518-3089, Vella Bonanno, Patricia and Godman, Brian (2017) The implementation of managed entry agreements in Central and Eastern Europe: findings and implications. PharmacoEconomics, 35 (12). pp. 1271-1285. ISSN 1170-7690

Kanavos, Panos ORCID: 0000-0001-9518-3089, Fontrier, Anna-Maria, Gill, Jennifer, Efthymiadou, Olina and Boekstein, Nicola (2017) The Impact of External Reference Pricing within and across Countries. . London School of Economics and Political Science, London, UK.

Kanavos, Panos ORCID: 0000-0001-9518-3089, Fontrier, Anna-Maria, Gill, Jennifer, Kyriopoulos, Dionysis and Boekstein, Nicola (2017) The Implementation of External Reference Pricing within and across Country Borders. . London School of Economics and Political Science, London, UK.

Angelis, Aris ORCID: 0000-0002-0261-4634, Montibeller, Gilberto, Hochhauser, Daniel and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2017) Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting. BMC Medical Informatics and Decision Making, 17 (149). ISSN 1472-6947

Tinelli, Michela ORCID: 0000-0002-8816-4389, Kanavos, Panos ORCID: 0000-0001-9518-3089, Efthymiadou, Olina, Visintin, Erica, Grimaccia, Federico and Mossman, Jean (2017) Using IMPrESS to guide policy change in multiple sclerosis. Multiple Sclerosis Journal, 24 (9). ISSN 1352-4585

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Kanavos, Panos ORCID: 0000-0001-9518-3089 and McKee, Martin (2017) Comparing generic drug markets in Europe and the United States: prices, volumes, and spending. The Milbank Quarterly, 95 (3). 554 - 601. ISSN 0887-378X

Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2017) Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: the Advance Value Framework. Social Science & Medicine, 188. pp. 137-156. ISSN 0277-9536

Tinelli, Michela ORCID: 0000-0002-8816-4389, Efthymiadou, Olina, Mossman, Jean and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2017) PROMS as predictors of healthcare use in multiple sclerosis. In: HTAiRome 2017, 2017-06-17 - 2017-06-21, Rome, Italy, ITA. (Submitted)

Gill, Jennifer, Kanavos, Panos ORCID: 0000-0001-9518-3089, Albanell, Joan, Dank, Magdolna, Duncombe, Robert, Fink-Wagner, Antje, Hutton, John, Jahnz-Różyk, Karina, Kossler, Ingrid, Podrazilova, Katerina, Schramm, Wolfgang, Spandonaro, Federico, Thomas, Michael and Wartenberg, Markus (2017) RWE in Europe Paper II: The use of Real World Evidence in the disease context. . London School of Economics and Political Science, London, UK.

Jackson, Timothy L., Nicod, Elena, Angelis, Aris ORCID: 0000-0002-0261-4634, Grimaccia, Federico, Pringle, Edward and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2017) Pars plana vitrectomy for diabetic macular edema: a systematic review, meta-analysis, and synthesis of safety literature. Retina, 37 (5). pp. 886-895. ISSN 1539-2864

Angelis, Aris ORCID: 0000-0002-0261-4634, Tordrup, David and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2017) Is the funding of public national health systems sustainable over the long term? Evidence from eight OECD countries. Global Policy, 8 (S2). pp. 7-22. ISSN 1758-5880

Wouters, Olivier J. ORCID: 0000-0002-2514-476X and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2017) A comparison of generic drug prices in seven European countries: a methodological analysis. BMC Health Services Research, 17 (242). pp. 1-7. ISSN 1472-6963

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2017) Health care after the Great Recession: financing options for sustainable and high-quality health systems. Global Policy, 8 (S2). pp. 5-6. ISSN 1758-5880

Angelis, Aris ORCID: 0000-0002-0261-4634, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Montibeller, Gilberto (2017) Resource allocation and priority setting in health care: a multi-criteria decision analysis problem of value? Global Policy, 8 (S2). pp. 76-83. ISSN 1758-5880

Kanavos, Panos ORCID: 0000-0001-9518-3089, Mills, Mackenzie, Cheatley, Jane, Lopez-Casasnovas, Guillem, Manganelli, Anton, Maynou, Laia and Serra, Miquel (2017) Controlling expenditure within the Spanish pharmaceutical market: macro- and micro-level policy approaches. . LSE Health, London, UK.

Gill, Jennifer, Albanell, Joan, Avouac, Bernard, Berger, Karin, Boerlum Kristensen, Finn, Bucher, Heiner C., Duncombe, Robert, Fink-Wagner, Antje-Henriette, Hutton, John, Jahnz-Różyk, Karina, Kossler, Ingrid, Podrazilova, Katerina, Spandonaro, Federico, Thomas, Michael, Vaz-Carneiro, Antonio, Wartenberg, Markus and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2017) RWE in Europe Paper III: A Roadmap for RWE. . London School of Economics and Political Science, London, UK.

Nicod, Elena, Jackson, Timothy L., Grimaccia, Federico, Angelis, Aris ORCID: 0000-0002-0261-4634, Costen, Marc, Haynes, Richard, Hughes, Edward, Pringle, Edward, Zambarakji, Hadi and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2016) Direct cost of pars plana vitrectomy for the treatment of macular hole, epiretinal membrane and vitreomacular traction: a bottom-up approach. European Journal of Health Economics, 17 (8). pp. 991-999. ISSN 1618-7598

Kanavos, Panos ORCID: 0000-0001-9518-3089, Tinelli, Michela ORCID: 0000-0002-8816-4389, Efthymiadou, O., Visintin, E., Grimaccia, Federico and Mossman, J. (2016) PND27 – the Impress (International Multiple Sclerosis) study; results on the socio-economic burden, health related quality of life and experience of multiple sclerosis patients in France. Value in Health, 19 (7). A429-A430. ISSN 1098-3015

Mossman, J., Efthymiadou, O., Tinelli, Michela ORCID: 0000-0002-8816-4389 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2016) PRM164 - reconsidering EQ-5D; quality of life domains that are important for Multiple Sclerosis patients. Value in Health, 19 (7). A387. ISSN 1098-3015

Bonser, Andrew, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Taylor, David (2016) Tender Loving Care? Purchasing medicines for continuing therapeutic improvement and better health outcomes. . London School of Economics and Political Science, London, UK.

Kanavos, Panos ORCID: 0000-0001-9518-3089, Tinelli, Michela ORCID: 0000-0002-8816-4389, Efthymiadou, Olina and Mossman, Jean (2016) The IMPrESS (International Multiple Sclerosis Study);socio-economic burden, health related quality of life andexperiences of multiple sclerosis patients in France. In: ISPOR 19th Annual European Congress, 2016-10-29 - 2016-11-02, Vienna, Austria, AUT.

Efthymiadou, Olina, Tinelli, Michela ORCID: 0000-0002-8816-4389, Mossman, Jean and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2016) Reconsidering EQ-5D; quality of life domains that are important for multiple sclerosis patients. In: ISPOR 19th Annual European Congress, 2016-10-29 - 2016-11-02, Vienna, Austria, AUT.

Mossman, Jean, Efthymiadou, Olina, Tinelli, Michela ORCID: 0000-0002-8816-4389 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2016) Health related quality of life aspects not captured by EQ-5D-5L: results from the IMPrESS (International MultiPlE SclerosiS) study. In: ISPOR 19th Annual European Congress, 2016-10-29 - 2016-11-02, Vienna, Austria, AUT.

Nicod, Elena and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2016) Scientific and social value judgments for orphan drugs in health technology assessment. International Journal of Technology Assessment in Health Care, 32 (4). pp. 218-232. ISSN 0266-4623

Tinelli, Michela ORCID: 0000-0002-8816-4389, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Mossman, J. (2016) Social economic costs, quality of life and experience in multiple sclerosis patients and their caregivers: the IMPrESS (International MultiPlE SclerosiS) survey. Multiple Sclerosis Journal, 22 (S3). pp. 148-149. ISSN 1352-4585

Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2016) Critique of the American Society of Clinical Oncology value assessment framework for cancer treatments: putting methodologic robustness first. Journal of Clinical Oncology, 34 (24). pp. 2935-2936. ISSN 0732-183X

Berg Brigham, Karen, Darlington, Meryl, Wright, John S. F., Lewison, Grant, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Durand-Zaleski, Isabelle (2016) Mapping research activity on mental health disorders in Europe: study protocol for the Mapping_NCD project. Health Research Policy and Systems, 14 (1). ISSN 1478-4505

Kanavos, Panos ORCID: 0000-0001-9518-3089, Tinelli, Michela ORCID: 0000-0002-8816-4389, Efthymiadou, Olina, Visintin, Erica, Grimaccia, Federico and Mossman, Jean (2016) Social impact of MS – the family burden. In: Asociaţia Pacienţilor cu Afecţiuni Autoimune - "Scleroza Multiplă nu trebuie să fie o povară"/Patients with Autoimmune Disorders Association - "Multiple sclerosis should not be a burden", 2016-05-25, Bucharest, Romania, ROM.

Kanavos, Panos ORCID: 0000-0001-9518-3089, Tinelli, Michela ORCID: 0000-0002-8816-4389, Efthymiadou, Olina and Mossman, Jean (2016) Moving towards better outcomes in Multiple Sclerosis by addressing policy change. In: HTAi 2016 Annual Meeting - Informing Health Care Decisions with Values and Evidence, 2016-05-10 - 2016-05-14, Tokyo, Japan, JPN.

Kanavos, Panos ORCID: 0000-0001-9518-3089, Tinelli, Michela ORCID: 0000-0002-8816-4389, Efthymiadou, Olina, Visintin, Erica, Grimaccia, Federico and Mossman, Jean (2016) Towards better outcomes in multiple sclerosis by addressing policy change: the International MultiPlE Sclerosis Study (IMPrESS). In: European Multiple Sclerosis Platform (EMSP) Spring Conference 2016, 2016-05-17 - 2016-05-18, Oslo, Norway, NOR.

Mossman, Jean, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Tinelli, Michela ORCID: 0000-0002-8816-4389 (2016) Changing the treatment paradigm in multiple sclerosis: are the attitudes of patients and physicians aligned? Neurology, 86 (16 Sup). 1.356. ISSN 0028-3878

Ferrario, Alessandra, Reinap, Marge, Pedersen, Hanne Bak and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2016) Availability of medicines in Estonia: an analysis of existing barriers and options to address them. . World Health Organization, Denmark.

Kanavos, Panos ORCID: 0000-0001-9518-3089, Tinelli, Michela ORCID: 0000-0002-8816-4389, Efthymiadou, Olina, Visintin, Erica, Grimaccia, Federico and Mossman, Jean (2016) Towards better outcomes in multiple sclerosis by addressing policy change: the International MultiPlE Sclerosis Study (IMPrESS). . London School of Economics and Political Science, London, UK.

Tinelli, Michela ORCID: 0000-0002-8816-4389, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Grimaccia, Federico (2016) The value of early diagnosis and treatment in Parkinson's disease: a literature review of the potential clinical and socioeconomic impact of targeting unmet needs in Parkinson’s disease. . London School of Economics and Political Science, London, UK.

Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2016) Value-based assessment of new medical technologies: towards a robust methodological framework for the application of multiple criteria decision analysis in the context of health technology assessment. PharmacoEconomics, 34 (5). pp. 435-446. ISSN 1170-7690

Nicod, Elena and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2016) Developing an evidence-based methodological framework to systematically compare HTA coverage decisions: a mixed methods study. Health Policy, 120 (1). pp. 35-45. ISSN 0168-8510

Gill, J. L., Baiceanu, A., Clark, P., Langford, A., Latiff, J., Wilson, A., Yang, P-M., Yoshida, E. and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2016) HCC patient voices survey. London School of Economics and Political Science, London, UK.

Ferrario, Alessandra, Kanavos, Panos ORCID: 0000-0001-9518-3089, Humbert, Tifenn, Iwamoto, Kotoji and Bak Pedersen, Hanne (2016) Challenges and opportunities in improving access to medicines through efficient public procurement in WHO European Region. . World Health Organization, Copenhagen, Denmark. ISBN 9789289052153

Gill, Jennifer, Kanavos, Panos ORCID: 0000-0001-9518-3089, Avouac, Bernard, Duncombe, Robert, Hutton, John, Jahnz-Różyk, Karina, Schramm, Wolfgang, Spandonaro, Federico and Thomas, Michael (2016) The use of Real World Evidence in the European context: An analysis of key expert opinion. . London School of Economics and Political Science, London, UK.

Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Large scale mergers and acquisitions in the pharmaceutical industry: 1 + 1 = 1? Health and Social Care Blog (12 Nov 2015). Website.

Cylus, Jonathan ORCID: 0000-0001-8269-1578, Wouters, Olivier J. ORCID: 0000-0002-2514-476X and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Understanding the role of governance in the pharmaceutical sector: from laboratory to patient. In: Greer, Scott, Wismar, Matthias and Figueras, Josep, (eds.) Strengthening Health System Governance: Better Policies, Stronger Performance. Open University, Maidenhead, UK, pp. 175-187. ISBN 9780335261345

Wouters, Olivier J. ORCID: 0000-0002-2514-476X and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Primary health care should play bigger role in treating chronic kidney disease. Health and Social Care at LSE (18 Oct 2015). Website.

Tinelli, Michela ORCID: 0000-0002-8816-4389, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Mossman, Jean (2015) Social economic costs, quality of life and experience in multiple sclerosis patients and their caregivers: the IMPrESS (International MultiPlE SclerosiS) survey. In: ECTRIMS 2016 - 32nd Congress of the European committee for the treatment and research in multiple sclerosis, 2016-09-14 - 2016-09-17, London, United Kingdom, GBR.

Angelis, Aris ORCID: 0000-0002-0261-4634, Tordrup, David and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Socio-economic burden of rare diseases: a systematic review of cost of illness evidence. Health Policy, 119 (7). pp. 964-979. ISSN 0168-8510

Wouters, Olivier J. ORCID: 0000-0002-2514-476X, O'Donoghue, Donal J., Ritchie, James, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Narva, Andrew S. (2015) Early chronic kidney disease: diagnosis, management and models of care. Nature Reviews Nephrology, 11 (8). pp. 491-502. ISSN 1759-5061

Tzouma, Victoria, Grepstad, Mari, Grimaccia, Federico and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Clinical, ethical, and socioeconomic considerations for prescription drug use during pregnancy in women suffering from chronic diseases. Therapeutic Innovation and Regulatory Science, 49 (6). pp. 947-956. ISSN 2168-4790

Kanavos, Panos ORCID: 0000-0001-9518-3089, Tinelli, Michela ORCID: 0000-0002-8816-4389 and Mossman, Jean (2015) Social economic costs, quality of life and experience in multiple sclerosis patients and their caregivers: the IMPrESS (International MultiPlE SclerosiS) survey. In: HTAi - Global Efforts in Knowledge Transfer: HTA to Health Policy and Practice, 2015-06-15 - 2015-06-17, Oslo, Norway, NOR.

Tinelli, Michela ORCID: 0000-0002-8816-4389, Kanavos, Panos ORCID: 0000-0001-9518-3089, Winkler, Petr, Knapp, Martin ORCID: 0000-0003-1427-0215, Höschl, Cyril and Pompili, Maurizio (2015) The impact of non-treatment of schizophrenia in OECD countries: a literature review. In: International Mental Health Congress (IMHC) - Mental Health for All: Connecting People and Sharing Experience, 2015-04-28 - 2015-04-30, Lille, France, FRA.

Tinelli, Michela ORCID: 0000-0002-8816-4389 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Cost and impact of non-treating severe mental illnesses (SMIs): the case study of schizophrenia. . London School of Economics and Political Science, London, UK.

Ferrario, Alessandra and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden. Social Science & Medicine, 124. pp. 39-47. ISSN 0277-9536

Khan, Usman, Pallot, Robert, Taylor, David and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Transatlantic Trade and Investment Partnership: international trade law, health systems and public health. . The London School of Economics and Political Science, Modus Europe, London, UK.

Wouters, Olivier J. ORCID: 0000-0002-2514-476X and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform. Bulletin of the World Health Organization, 93 (9). pp. 606-613. ISSN 0042-9686

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Angelis, Aris ORCID: 0000-0002-0261-4634 (2014) Acquiring pharmaceutical industry assets in the UK: 1 + 1 = 1? Pharmaceutical Medicine, online. ISSN 1178-2595

Tordrup, David, Tzouma, Victoria and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2014) Orphan drug considerations in Health Technology Assessment ineight European countries. Rare Diseases and Orphan Drugs: An International Journal of Public Health, 1 (3). pp. 86-97.

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2014) Pharmaceutical policies in Cyprus: a review of the current system and future options. . World Health Organization, Copenhagen, Denmark.

Grimaccia, Federico and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2014) Cost, outcomes, treatment pathways and challenges for diabetes care in Italy. Globalization and Health, 10 (58). ISSN 1744-8603

Vandoros, Sotiris and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2014) Parallel trade and pharmaceutical prices: a game-theoretic approach and empirical evidence from the European Union. World Economy, 37 (6). pp. 856-880. ISSN 0378-5920

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2014) Pharmaceutical parallel trade: legal, policy, and economic issues. In: Culyer, Anthony J., (ed.) Encyclopedia of health economics. Elsevier (Firm), San Diego, USA, pp. 20-28. ISBN 9780123756787

Ferrario, Alessandra, Sautenkova, Nina, Bezverhni, Zinaida, Seicas, Rita, Habicht, Jarno, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Safta, Vladimir (2014) An in-depth analysis of pharmaceutical regulation in the Republic of Moldova. Journal of Pharmaceutical Policy and Practice, 7 (1). p. 4. ISSN 2052-3211

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2014) Concurrence dans la distribution de produits pharmaceutiques. In: OECD Forum Mondial sur la Concurrence, 2014-02-27 - 2014-02-28, Paris, France, FRA.

Tordrup, David, Mossman, Jean and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2014) Responsiveness of the EQ-5D to clinical change: is the patient experience adequately represented? International Journal of Technology Assessment in Health Care, 30 (01). pp. 10-19. ISSN 0266-4623

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2014) Competition issues in the distribution of pharmaceuticals. In: OECD Global Forum on Competition, 2014-02-27 - 2014-02-28, Paris, France, FRA.

Kanavos, Panos ORCID: 0000-0001-9518-3089 (2014) Measuring performance in off-patent drug markets: a methodological framework and empirical evidence from twelve EU Member States. Health Policy, 118 (2). pp. 229-241. ISSN 0168-8510

Bertoldi, Andréa D., Kanavos, Panos ORCID: 0000-0001-9518-3089, França, Giovanny V. A., Carraro, André, Tejada, Cesar Augusto, Hallal, Pedro C., Ferrario, Alessandra and Schmidt, Maria (2013) Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Globalization and Health, 9 (1). p. 62. ISSN 1744-8603

Tordrup, David, Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2013) Preferences on policy options for ensuring the financial sustainability of health care services in the future: results of a stakeholder survey. Applied Health Economics and Health Policy, 11 (6). pp. 639-652. ISSN 1175-5652

Ferrario, Alessandra and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2013) The LSE Summit: risk sharing and managed entry agreements. Health and Social Care at LSE (20 Nov 2013). Website.

Jackson, Timothy L., Nicod, Elena, Angelis, Aris ORCID: 0000-0002-0261-4634, Grimaccia, Federico, Prevost, Andrew T., Simpson, Andrew R.H. and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2013) Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy. Retina, 33 (10). pp. 2012-2017. ISSN 0275-004X

Ferrario, Alessandra and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2013) Progress in addressing the growing diabetes epidemic is lagging behind due to poor control of the disease. Health and Social Care at LSE (19 Jun 2013). Website.

Jackson, Timothy L., Nicod, Elena, Angelis, Aris ORCID: 0000-0002-0261-4634, Grimaccia, Federico, Prevost, Toby, Simpson, Andrew and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2013) Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. Retina, 33 (6). pp. 1099-1108. ISSN 1539-2864

Kanavos, Panos ORCID: 0000-0001-9518-3089, Ferrario, Alessandra, Vandoros, Sotiris and Anderson, Gerard F. (2013) Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs. Health Affairs, 32 (4). pp. 753-761. ISSN 0278-2715

Ferrario, Alessandra and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2013) Managed entry agreements for pharmaceuticals: the European experience. . EMiNet, Brussels, Belgium.

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Angelis, Aris ORCID: 0000-0002-0261-4634 (2013) Multiple criteria decision analysis for valuebased assessment of new medical technologies:a conceptual framework. LSE Health working papers (33). LSE Health, London, UK.

Kanavos, Panos ORCID: 0000-0001-9518-3089 (2013) Toward greater efficiency and equity in healthcare resource allocation: Dr Panos Kanavos to lead consortium in ADVANCE_HTA European Commission FP7 grant. LSE Health and Social Care (15 Feb 2013). Website.

Tordrup, David, Ahmed, Waqas, Bukhari, Khalid Saeed and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2013) Availability of medical supplies during the 2010 Pakistan floods. The Lancet Global Health, 1 (1). e13-e14. ISSN 2214-109X

Jackson, Timothy, Nicod, Elena, Simpson, Andrew, Angelis, Aris ORCID: 0000-0002-0261-4634, Grimaccia, Federico and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2013) Symptomatic vitreomacular adhesion. Retina, 33 (8). pp. 1503-1511. ISSN 1539-2864

Vandoros, Sotiris and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2013) The generics paradox revisited: empirical evidence from regulated markets. Applied Economics, 45 (22). pp. 3230-3239. ISSN 0003-6846

Nicod, Elena and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2012) Commonalities and differences in HTA outcomes: a comparative analysis of five countries and implications for coverage decisions. Health Policy, 108 (2-3). pp. 167-177. ISSN 0168-8510

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Nicod, Elena (2012) What is wrong with orphan drug policies?: suggestions for ways forward. Value in Health, 15 (8). pp. 1182-1184. ISSN 1098-3015

Linertová, Renata, Serrano-Aguilar, Pedro, Posada-de-la-Paz, Manuel, Hens-Pérez, Manuel, Kanavos, Panos ORCID: 0000-0001-9518-3089, Taruscio, Domenica, Schieppati, Arrigo, Stefanov, Rumen, Péntek, Márta, Delgado, Claudia, Graf von der Schulenburg, Johann-Matthias, Persson, Ulf, Chevreul, Karine, Fattore, Giovanni, Worbes-Cerezo, Melany, Sefton, Mark and López-Bastida, Julio (2012) Delphi approach to select rare diseases for a European representative survey: the BURQOL-RD study. Health Policy, 108 (1). pp. 19-26. ISSN 0168-8510

Prinja, Shankar, Aggarwal, Arun Kumar, Kumar, Rajesh and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2012) User charges in health care: evidence of effect on service utilization & equity from north India. Indian Journal of Medical Research, Supplement, 136. pp. 868-876. ISSN 0367-9012

Prinja, Shankar, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Kumar, Rajesh (2012) Health care inequities in north India: role of public sector in universalizing health care. Indian Journal of Medical Research, 136. pp. 421-431. ISSN 0971-5916

Helfer, Ana Paula, Camargo, Aline Lins, Tavares, Noemia Urruth Leão, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Bertoldi, Andréa Dâmaso (2012) Capacidade aquisitiva e disponibilidade de medicamentos para doenças crônicas no setor público. Revista Panamericana de Salud Pública/Pan American Journal of Public Health, 31 (3). pp. 225-232. ISSN 1020-4989

Sautenkova, Nina, Ferrario, Alessandra, Bolokhovets, Ganna and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2012) Availability and affordability of medicines and assessment of quality systems for prescription of medicines in the Republic of Moldova: final report. Health policy paper series (no. 6). World Health Organization Regional Office for Europe, Copenhagen, Denmark.

Von der Schulenburg, Fritz, Vandoros, Sotiris and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2011) The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors. Health Economics Review, 1 (1). pp. 1-8. ISSN 2191-1991

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Vandoros, Sotiris (2011) Determinants of branded prescription medicine prices in OECD countries. Health Economics, Policy and Law, 6 (3). pp. 1-31. ISSN 1744-1331

Sorenson, Corinna and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2011) Medical technology procurement in Europe: a cross-country comparison of current practice and policy. Health Policy, 100 (1). pp. 43-50. ISSN 0168-8510

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Vandoros, Sotiris (2011) Drugs US: are prices too high?: measuring international pharmaceutical price differences. Significance, 8 (1). pp. 15-18. ISSN 1740-9705

Kanavos, Panos ORCID: 0000-0001-9518-3089, Schurer, Willemien and Vogler, Sabine (2011) The pharmaceutical distribution chain in the European Union: structure and impact on pharmaceutical prices. . European Commission, Brussels, Belgium.

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Gemmill-Toyama, Marin (2010) Prescription drug coverage among elderly and disabled Americans: can Medicare—Part D reduce inequities in access? International Journal of Health Care Finance and Economics, 10 (3). pp. 203-218. ISSN 1389-6563

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Vandoros, Sotiris (2010) Competition in prescription drug markets: is parallel trade the answer? Managerial and Decision Economics, 31 (5). pp. 325-338. ISSN 0143-6570

Lluch, Maria and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2010) Impact of regulation of community pharmacies on efficiency, access and equity. Evidence from the UK and Spain. Health Policy, 95 (2-3). pp. 245-254. ISSN 0168-8510

Kanavos, Panos ORCID: 0000-0001-9518-3089, Sullivan, R., Lewison, G., Schurer, W., Eckhouse, S. and Vlachopioti, Z. (2010) The role of funding and policies on innovation in cancer drug development. Ecancermedicalscience, 4. ISSN 1754-6605

Kanavos, Panos ORCID: 0000-0001-9518-3089, Nicod, Elena, Espin, Jaime and van den Aardweg, Stacey (2010) Short- and long-term effects of value-based pricingvs. external price referencing. . EMiNet.

Geitona, Mary and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2010) Colocteral cancer management and prevention policies in Greece. European Journal of Health Economics, 10 (Supp.1). pp. 27-33. ISSN 1618-7598

Schurer, Willemien and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2010) Colorectal cancer management in the United Kingdom: current practice and challenges. European Journal of Health Economics, 10 (Supp.1). pp. 85-90. ISSN 1618-7598

Kanavos, Panos ORCID: 0000-0001-9518-3089, Vandoros, Sotiris, Irwin, Rachel, Nicod, Elena and Casson, Margaret (2010) The European pharmaceutical market and policies - outlook for the future. . European Parliament, Brussels, Belgium.

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Schurer, Willemien (2010) The burden of colorectal cancer: prevention, treatment and quality of services. European Journal of Health Economics, 10 (Supp.1). pp. 1-3. ISSN 1618-7598

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Schurer, Willemien (2010) The dynamics of colorectal cancer management in 17 countries. European Journal of Health Economics, 10 (Supp.1). pp. 115-129. ISSN 1618-7598

Kanavos, Panos ORCID: 0000-0001-9518-3089, Nicod, Elena, van den Aardweg, Stacey and Pomedli, Stephen (2010) The impact of health technology assessments: an international comparison. Euro Observer, 12 (4). pp. 1-7. ISSN 1020-7481

Kanavos, Panos ORCID: 0000-0001-9518-3089, Seeley, Elizabeth and Vandoros, Sotiris (2009) Tender systems for outpatient pharmaceuticals in the European Union: evidence from the Netherlands, Germany and Belgium. . Enterprise and Industry, European Commission, Brussels, Belgium.

Sorenson, Corinna, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Karamalis, M. (2009) HTA in Central and Eastern Europe: current status, challenges and opportunities. Journal of Medical Device Regulation, 6 (1). pp. 34-45. ISSN 1759-149X

Kanavos, Panos ORCID: 0000-0001-9518-3089, Vandoros, Sotiris and Garcia-Gonzalez, Pat (2009) Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP. Globalization and Health, 5 (19). pp. 1-13. ISSN 1744-8603

Kanavos, Panos ORCID: 0000-0001-9518-3089, Vandoros, Sotiris, Habicht, Jarno and de Joncheere, Kees (2009) Review of the Estonian pharmaceutical sector: towards the development of a national medicines policy. . Regional Office for Europe, World Health Organization, Copenhagen, Denmark.

Sorenson, Corinna and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2009) Topic 1: financing medical devices in France and the UK. . European Health Technology Institute on Socio-Economic Research.

Sorenson, Corinna, Drummond, Michael, Kanavos, Panos ORCID: 0000-0001-9518-3089 and McGuire, Alistair ORCID: 0000-0002-5367-9841 (2008) Does the work of the National Institute for Health and Clinical Excellence (NICE) have any relevance for the United States? ISPOR Connections, 14 (4). pp. 7-9. ISSN 1538-5108

Kanavos, Panos ORCID: 0000-0001-9518-3089, Schurer, Willemien, Owusu-Apenten, Candida and Sullivan, Richard (2008) Colorectal cancer in Europe and Australia: challenges and opportunities for the future. . LSE Health, London School of Economics and Political Science, London, UK. ISBN 9780853283027

Sorenson, Corinna, Drummond, Michael, Kanavos, Panos ORCID: 0000-0001-9518-3089 and McGuire, Alistair ORCID: 0000-0002-5367-9841 (2008) National Institute for Health and Clinical Excellence (NICE). How does it work and what are the implications for the U.S? . National Pharmaceutical Council, Virginia, USA.

Kanavos, Panos ORCID: 0000-0001-9518-3089, Costa-i-Font, Joan ORCID: 0000-0001-7174-7919 and Seeley, Elizabeth (2008) Competition in off-patent drug markets: issues, regulation and evidence. Economic Policy, 23 (55). pp. 499-544. ISSN 0266-4658

McGuire, Alistair ORCID: 0000-0002-5367-9841, Raikou, Maria and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2008) Pricing pharmaceuticals: value based pricing in what sense? Eurohealth, 14 (2). pp. 3-6. ISSN 1356-1030

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Vandoros, Sotiris (2008) Validation of the Russian federal prescribing database and evaluation of policy outcomes. . Russian Federal Bureau of Obligatory Medical Insurance.

Costa-i-Font, Joan ORCID: 0000-0001-7174-7919 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2007) Medicines in parallel trade in the European Union: a gravity specification. LSE Health working papers (6/2007). London School of Economics and Political Science, London, UK.

Sorenson, Corinna, Drummond, Michael and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2007) Ensuring value for money in health care: The role of HTA in the European Union. In: Financing sustainable healthcare in Europe: New approaches for new outcomes, 2007-02-07 - 2007-02-08, Helsinki, Finland, FIN.

Kanavos, Panos ORCID: 0000-0001-9518-3089 (2007) Do generics offer significant savings to the UK National Health Service? Current Medical Research and Opinion, vol. 23(1). Current Medical Research and Opinion, 23 (1). pp. 105-116. ISSN 0300-7995

Costa-i-Font, Joan ORCID: 0000-0001-7174-7919, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Rovira-Forns, Joan (2007) Determinants of out-of-pocket pharmaceutical expenditure and access to drugs in Catalonia. Applied Economics, 39 (5). pp. 541-551. ISSN 0003-6846

Costa-i-Font, Joan ORCID: 0000-0001-7174-7919 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2007) Importaciones paralelas de medicamentos: El caso de la Simvastaina en Alemania, Holanda y el Reino Unido. Gaceta Sanitaria, 21 (1). pp. 53-59. ISSN 0213-9111

Kanavos, Panos ORCID: 0000-0001-9518-3089, Costa-i-Font, Joan ORCID: 0000-0001-7174-7919 and McGuire, Alistair ORCID: 0000-0002-5367-9841 (2007) Product differentiation, competition and regulation of new drugs: the case of statins in four European countries. Managerial and Decision Economics, 28 (4-5). pp. 455-465. ISSN 1099-1468

Gemmill, Marin, Costa-i-Font, Joan ORCID: 0000-0001-7174-7919 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2006) Insurance coverage and the heterogeneity of health and drug spending in the United States. Geneva Papers on Risk and Insurance: Issues and Practice, 31 (4). pp. 669-691. ISSN 1018-5895

Morgan, S, McMahon, M, Mitton, C, Rougehead, E, Kirk, R, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Menom, D (2006) Centralized drug review processes in Australia, Canada, New Zealand, and the United Kingdom. Health Affairs, 25 (2). pp. 337-347. ISSN 0278-2715

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Saka, R (2006) Economic evaluation for orphan drugs: is it possible? Eurohealth. ISSN 1356-1030

Kanavos, Panos ORCID: 0000-0001-9518-3089, Ustel, I., Tatar, M. and Costa-i-Font, Joan ORCID: 0000-0001-7174-7919 (2006) Health and drug sector reform in Turkey: caveats and opportunities. . Health and Social Care, London School of Economics and Political Science, London, UK.

Tatar, Mehtap and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2006) Health care reform in Turkey: a dynamic path in the wake of political consensus. Eurohealth, 12 (1). pp. 20-22. ISSN 1356-1030

Kanavos, Panos ORCID: 0000-0001-9518-3089, Yfantopoulos, J., Politis, C. and Vandoros, C. (2006) The economics of blood: gift of life or a commodity? International Journal of Technology Assessment in Health Care, 22 (3). pp. 338-343. ISSN 0266-4623

Kanavos, Panos ORCID: 0000-0001-9518-3089 (2006) The rising burden of cancer in the developing world. Annals of Oncology, 17 (Supple). ISSN 0923-7534

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Costa-i-Font, Joan ORCID: 0000-0001-7174-7919 (2005) Pharmaceutical parallel trade in Europe: stakeholders and competition effects. Economic Policy, 20 (44). pp. 751-798. ISSN 0266-4658

Park, Sylvia, Ross-Degnan, Dennis, Adams, Alyce S, Sabin, James, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Soumerai, Stephen B (2005) Effect of switching antipsychotics on antiparkinsonian medication use in schizophrenia: a population-based study. British Journal of Psychiatry, 187 (2). pp. 137-142. ISSN 0007-1250

Kanavos, Panos ORCID: 0000-0001-9518-3089, Gross, David and Taylor, David (2005) Parallel trading in medicines: Europe’s experience and its implications for commercial drug importation in the United States. . American Association for Retired Persons, Washington, DC., USA.

Knapp, Martin ORCID: 0000-0003-1427-0215, Kanavos, Panos ORCID: 0000-0001-9518-3089, King, Derek ORCID: 0000-0002-2408-4558 and Yesudian, Hannah Monica (2005) Economic issues in access to medications: Schizophrenia treatment in England. International Journal of Law and Psychiatry, 28 (5). pp. 514-531. ISSN 0160-2527

Costa-i-Font, Joan ORCID: 0000-0001-7174-7919 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2005) Efectos del comercio paralelo de medicamentos en la Unión Europea y evidencia de Alemania. Boletin de Estudios Economicos, 60 (185). pp. 251-263. ISSN 0006-6249

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Saka, Ömer R (2005) How should functionally equivalent drugs be reimbursed? A retrospective analysis of reimbursement for Epoetin-[alpha] and Darbepoetin-[alpha] in 2001-2003 and the cost implications for CMS. Disease Management and Health Outcomes, 13 (6). pp. 359-370. ISSN 1173-8790

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Saka, O (2005) How should functionally equivalent drugs be reimbursed?: A retrospective analysis of reimbursement for epoetin alfa and Darbepoetin alfa in 2001–3 and the cost implications for CMS. Disease Management and Health Outcomes, 13 (6). pp. 359-370. ISSN 1173-8790

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Gemmill, Marin (2005) Pharmaceutical pricing and reimbursement in Europe. Scrip reports. Scrip (Firm), London.

Kanavos, Panos ORCID: 0000-0001-9518-3089, Ustel, Ismail and Costa-Font, Joan ORCID: 0000-0001-7174-7919 (2005) Türkiye'de ilaç geri ödeme politikası. Sağlıkta Umut Vakfı, Ankara. ISBN 9750037014

Kanavos, Panos ORCID: 0000-0001-9518-3089, Costa-i-Font, Joan ORCID: 0000-0001-7174-7919, Merkur, S. and Gemmill, M. (2004) The economic impact of pharmaceutical parallel trade in European union member states: a stakeholder analysis. Special Research Paper. London School of Economics and Political Science, London, UK. ISBN 0753017261

Kanavos, Panos ORCID: 0000-0001-9518-3089 (2004) European pharmaceutical policy and implications for current member States and pre-accession countries. In: McKee, Martin and McLehose, Laura, (eds.) Health Policy and European Union Enlargement. Open University, pp. 240-264. ISBN 0335213537

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Holmes, P. R. (2004) Financial flows to global health partnerships. . Department for International Development, London, UK.

Kanavos, Panos ORCID: 0000-0001-9518-3089, Soumerai, Stephen B and Ross-Degnan, Dennis (2004) Measuring, monitoring and evaluating policy outcomes in the pharmaceutical sector. In: Mossialos, Elias, Mrazek, Monique F. and Walley, Tom, (eds.) Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality. Open University Press on behalf of the European Observatory on Health Systems and Policies, Maidenhead, UK, pp. 97-113. ISBN 9780335214655

Kanavos, Panos ORCID: 0000-0001-9518-3089, Tatar, D and Taylor, D (2004) Regulating pharmaceutical distribution and retail pharmacy in Europe. In: Mossialos, Elias, Mrazek, M and Walley, T, (eds.) Regulating Pharmaceuticals in Europe : Striving for Efficiency, Equity and Quality. Open University, Maidenhead, UK, pp. 196-212. ISBN 0335214657

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Gemmill, M (2004) Senior citizens and the burden of prescription drug outlays: what lessons for the Medicare prescription drug benefit? Applied Health Economics and Health Policy, 3 (4). pp. 217-227. ISSN 1175-5652

Kanavos, Panos ORCID: 0000-0001-9518-3089 (2003) Implications of financing systems. In: Zollner, H, Stoddart, G and Selby Smith, C, (eds.) Learning to Live With Health Economics. World Health Organization for Europe, pp. 69-86.

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2003) Managing healthcare reform: evaluation of available options. In: Stoddart, G, Zollner, H and Selby-Smith, C, (eds.) Learning to Live With Healthcare Reform. World Health Organization Regional Office for Europe, Copenhagan, Denmark.

Kanavos, Panos ORCID: 0000-0001-9518-3089 (2003) Reference pricing for drugs: is it compatible with US healthcare? Health Affairs, 22 (3). pp. 16-30. ISSN 0278-2715

Kanavos, Panos ORCID: 0000-0001-9518-3089 (2002) Pharmaceutical regulation in Europe. In: Institute for Research on Public Policy Conference – Toward a National Strategy on Drug Insurance: Challenges and Priorities, 2002-09-23, Toronto, Canada, CAN. (Submitted)

King, Derek R. ORCID: 0000-0002-2408-4558 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2002) Encouraging the use of generic medicines: implications for transition economies. Croatian Medical Journal, 43 (4). pp. 462-469. ISSN 0353-9504

Kanavos, Panos ORCID: 0000-0001-9518-3089, Lim, J Y and Pascual, C S (2002) On improving accessibility of drugs for the poor. Philippines health policy note. World Bank.

Kanavos, Panos ORCID: 0000-0001-9518-3089 (2002) EU pharmaceutical policy: the challenges and opportunities of enlargement. Eurohealth, 8 (4). pp. 24-26. ISSN 1356-1030

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2002) Evaluation of health care reform options. In: Zollner, H, Stoddart, G and Selby Smith, C, (eds.) Learning to Live With Health Economics. World Health Organization Regional Office for Europe, pp. 37-48.

Kanavos, Panos ORCID: 0000-0001-9518-3089, Lim, J Y and Pascual, C S (2002) On improving the poor's access to affordable drugs. . World Bank.

Exworthy, M. and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2001) Cross-border patient flows for health care in Europe: A feasibility study. . U.K. Deapartment of Health, London, U.K..

Kanavos, Panos ORCID: 0000-0001-9518-3089 (2001) Overview of pharmaceutical pricing and reimbursement regulation. . LSE Health, London, U.K..

Kanavos, Panos ORCID: 0000-0001-9518-3089, Trueman, P and Bosilevac, A (2000) Can economic evaluation guidelines improve efficiency in resource allocation? International Journal of Technology Assessment in Health Care, 16 (4). pp. 1179-1192. ISSN 0266-4623

Kanavos, Panos ORCID: 0000-0001-9518-3089 and McKee, Martin (2000) Cross-border issues in the provision of health services: are we moving towards a European health policy? Journal of Health Services Research and Policy, 5 (4). pp. 231-236. ISSN 1355-8196

Maynard, Alan and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2000) Health economics: an evolving paradigm. Health Economics, 9 (3). pp. 183-190. ISSN 1057-9230

Kanavos, Panos ORCID: 0000-0001-9518-3089 (2000) Towards evidence-based decisions in health care: a prospective assessment of training needs in health economics and management in the European Union. Hepac Health Economics in Prevention and Care, 1 (1). pp. 78-90. ISSN 1439-3972

Trueman, P., Kanavos, Panos ORCID: 0000-0001-9518-3089 and Wallace, M. (2000) The increasing use of economic evaluation of pharmaceuticals, part 1: guidelines for economic evaluation and their role in health policy. Clinical Research Focus, 11 (1). pp. 23-29. ISSN 0968-0594

Trueman, P., Kanavos, Panos ORCID: 0000-0001-9518-3089 and Wallace, M. (2000) The increasing use of economic evaluation of pharmaceuticals, part 2: 'the fourth hurdle': what does it mean for drug development? Clinical Research Focus, 11 (2). pp. 24-29. ISSN 0968-0594

Kanavos, Panos ORCID: 0000-0001-9518-3089 (2000) The single market for pharmaceuticals in the European Union in light of European Court of Justice rulings. PharmacoEconomics, 18 (6). pp. 523-532. ISSN 1170-7690

Kanavos, Panos ORCID: 0000-0001-9518-3089 (1999) Financing pharmaceuticals in transition. Croatian Medical Journal, 40 (June). pp. 244-259. ISSN 0353-9504

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Mossialos, Elias ORCID: 0000-0001-8664-9297 (1999) Outstanding regulatory issues in the European Union pharmaceutical market. PharmacoEconomics, 15 (6). pp. 519-533. ISSN 1170-7690

Mossialos, Elias ORCID: 0000-0001-8664-9297, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Abel-Smith, B. (1994) Policy options for pharmaceutical research and development in the European Community. Science and Technology Options Assessment Programme. European Parliament, Brussels, Belgium.